Sermes

Sermes is a well-established, private contract research organization based in Madrid, Spain, with nearly three decades of experience in the drug development services sector. The company leverages its expertise in formulation and analytical sciences to support clients in advancing small molecule therapeutics through preclinical and clinical stages. As a service provider, its business model is revenue-generating, dependent on the R&D outsourcing trends of the biopharma industry. Its position allows it to capitalize on the growing demand for specialized CRO services in Europe and beyond.

Integrated CRO service platform specializing in formulation sciences, analytical development, and clinical trial support for small molecules and drug delivery systems.

Sermes operates in a highly competitive and fragmented global CRO market. It competes with large, full-service multinational CROs (e.g., IQVIA, Parexel) and smaller, specialized service providers. Its differentiation likely hinges on its deep expertise in formulation and drug delivery for small molecules, its regional focus in Spain/Europe, and a client-service approach as a mid-sized, agile partner.